PE20171309A1 - Metodo para la elaboracion de naltrexona - Google Patents
Metodo para la elaboracion de naltrexonaInfo
- Publication number
- PE20171309A1 PE20171309A1 PE2017001285A PE2017001285A PE20171309A1 PE 20171309 A1 PE20171309 A1 PE 20171309A1 PE 2017001285 A PE2017001285 A PE 2017001285A PE 2017001285 A PE2017001285 A PE 2017001285A PE 20171309 A1 PE20171309 A1 PE 20171309A1
- Authority
- PE
- Peru
- Prior art keywords
- noroxymorphone
- weight
- naltrexone
- preparation
- pyrrolidone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Abstract
REFERIDA A UN PROCESO PARA LA ELABORACION DE NALTREXONA QUE COMPRENDE: A) HACER REACCIONAR NOROXIMORFONA CON CICLOPROPILMETIL HALURO TAL COMO CICLOPROPILMETIL BROMURO EN PRESENCIA DE N-ETIL-2-PIRROLIDONA, DONDE LA RELACION MOLAR ENTRE N-ETIL-2-PIRROLIDONA Y NOROXIMORFONA ES ENTRE 0,5:1 A 10:1 EN PESO, Y LA RELACION MOLAR ENTRE NOROXIMORFONA Y EL CICLOPROPILMETIL HALURO ES ENTRE 1:1 A 1:2 EN PESO; B) ADICIONAR UN DEPURADOR ACIDO TAL COMO KHCO3 Y N,N-DIISOPROPILETILAMINA, DONDE LA RELACION MOLAR ENTRE NOROXIMORFONA Y EL DEPURADOR ACIDO ES ENTRE 1:0,5 A 1:2 EN PESO; Y C) CALENTAR LA MEZCLA A UNA TEMPERATURA ENTRE 30°C A 100°C DURANTE 8 A 48 HORAS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201001007 | 2010-11-05 | ||
DKPA201100396 | 2011-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20171309A1 true PE20171309A1 (es) | 2017-09-05 |
Family
ID=46552826
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2013000948A PE20140357A1 (es) | 2010-11-05 | 2011-11-04 | Metodo para la elaboracion de naltrexona |
PE2017001285A PE20171309A1 (es) | 2010-11-05 | 2011-11-04 | Metodo para la elaboracion de naltrexona |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2013000948A PE20140357A1 (es) | 2010-11-05 | 2011-11-04 | Metodo para la elaboracion de naltrexona |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR101837795B1 (es) |
CN (1) | CN103237804B (es) |
AR (1) | AR087142A1 (es) |
BR (1) | BR112013009407B8 (es) |
CL (1) | CL2013001251A1 (es) |
CO (1) | CO6700868A2 (es) |
IL (1) | IL225790A (es) |
JO (1) | JO3209B1 (es) |
PE (2) | PE20140357A1 (es) |
SG (1) | SG189369A1 (es) |
TW (1) | TWI516491B (es) |
ZA (1) | ZA201303224B (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0496830B1 (en) * | 1989-10-16 | 1999-03-31 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates |
UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
FR2906252B1 (fr) * | 2006-09-21 | 2008-11-28 | Sanofi Aventis Sa | Procede de preparation d'halogenures de n-aklyl naltrexone |
WO2008138383A1 (de) * | 2007-05-16 | 2008-11-20 | Cilag Ag | Verfahren zur herstellung von n-methylnaltrexonbromid |
WO2010039209A2 (en) * | 2008-09-30 | 2010-04-08 | Mallinckrodt Inc. | Processes for the synthesis of tertiary amines |
-
2011
- 2011-10-31 JO JOP/2011/0328A patent/JO3209B1/ar active
- 2011-11-01 TW TW100139692A patent/TWI516491B/zh not_active IP Right Cessation
- 2011-11-03 AR ARP110104090A patent/AR087142A1/es unknown
- 2011-11-04 PE PE2013000948A patent/PE20140357A1/es not_active Application Discontinuation
- 2011-11-04 BR BR112013009407A patent/BR112013009407B8/pt active IP Right Grant
- 2011-11-04 CN CN201180053349.6A patent/CN103237804B/zh active Active
- 2011-11-04 PE PE2017001285A patent/PE20171309A1/es not_active Application Discontinuation
- 2011-11-04 SG SG2013027412A patent/SG189369A1/en unknown
- 2011-11-04 KR KR1020137011320A patent/KR101837795B1/ko active IP Right Grant
-
2013
- 2013-04-17 IL IL225790A patent/IL225790A/en active IP Right Grant
- 2013-05-03 ZA ZA2013/03224A patent/ZA201303224B/en unknown
- 2013-05-03 CO CO13111250A patent/CO6700868A2/es active IP Right Grant
- 2013-05-06 CL CL2013001251A patent/CL2013001251A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR087142A1 (es) | 2014-02-26 |
BR112013009407A2 (pt) | 2016-07-19 |
JO3209B1 (ar) | 2018-03-08 |
KR101837795B1 (ko) | 2018-03-12 |
PE20140357A1 (es) | 2014-03-29 |
CO6700868A2 (es) | 2013-06-28 |
IL225790A (en) | 2016-07-31 |
BR112013009407B8 (pt) | 2022-11-22 |
CN103237804B (zh) | 2016-06-08 |
IL225790A0 (en) | 2013-06-27 |
TW201219396A (en) | 2012-05-16 |
CN103237804A (zh) | 2013-08-07 |
SG189369A1 (en) | 2013-05-31 |
CL2013001251A1 (es) | 2013-08-30 |
BR112013009407B1 (pt) | 2021-07-20 |
TWI516491B (zh) | 2016-01-11 |
ZA201303224B (en) | 2014-07-30 |
KR20130129928A (ko) | 2013-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014007674A2 (pt) | método para produzir derivados de 4,4-diflúor-3,4-dihidroisoquinolina | |
PH12015502839A1 (en) | Antiviral compounds | |
WO2014128545A3 (en) | An improved process for the preparation of dolutegravir | |
AR092278A1 (es) | Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados | |
PE20140969A1 (es) | Combinacion de analogos del glucagon acilados con analogos de insulina | |
WO2013128294A3 (en) | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent | |
NZ601805A (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
EA201171466A1 (ru) | Композиция неслеживающейся соли, способ ее получения и использование | |
AR085052A1 (es) | Metodos para producir un compuesto profarmaco inhibidor de la union al vih e intermediarios | |
MX2013010626A (es) | Metodo para producir nanofilamentos de plata. | |
UA111868C2 (uk) | Спосіб одержання естерів (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)-оцтової кислоти | |
PH12014502779B1 (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
CO6341607A2 (es) | Metodo de sintesis de sevoflurano | |
AR093406A1 (es) | Metodo para la produccion de acido peracetico en equilibrio, y acido peracetico en equilibrio que se puede obtener con dicho metodo | |
IN2015DN01009A (es) | ||
CL2012000739A1 (es) | Procedimientos de preparacion del acido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotinico; y uno de los compuestos intermedios considerados. | |
CL2014002029A1 (es) | Método para preparar un compuesto de formula 1 mediante la reacción de adición de michael , usando agua o acido o una mezcla de los mismos como aditivo, entre un compuesto de formula 2 y un compuesto de formula 3 en presencia de polvo de cobre. | |
AR095548A1 (es) | Preparación de ácido 4-amino-2,4-dioxobutanoico | |
PE20171309A1 (es) | Metodo para la elaboracion de naltrexona | |
AR086220A1 (es) | Proceso para la produccion de cloruro de 4-cloroacetoacetilo, y esteres, amidas e imidas del acido 4-cloroacetoacetico | |
UY33342A (es) | Proceso para la preparación de amidas de ácido pirazol carboxílico | |
CN106687441A8 (zh) | 用于将第一化合物偶合到第二化合物的方法 | |
UA111329C2 (uk) | Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою | |
AR090916A1 (es) | Metodo para la fabricacion de naltrexona | |
CY1120482T1 (el) | Μεθοδος συνθεσης 3,4-διμεθοξυδικυκλο[4.2.0]οκτα-1,3,5-τριενο-7-καρβονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |